Brainstorm Cell Therapeutics Inc. (BCLI)
Stock-Based Compensation
$2.68M
TTM · Period ending: · USD
BCLI Stock-Based Compensation
Latest reported$2.68Mperiod ending
Latest reported$2.68Mperiod ending
BCLI Stock-Based Comp ($0.00 → $2.68M)
Annual stock-based compensation
High-resolution chart · PNG
BCLI stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 1,520,000 | |
| 750,000 | |
| 1,490,000 | |
| 1,682,000 | |
| 1,366,000 | |
| 2,560,000 | |
| 789,000 | |
| 917,000 | |
| 554,000 | |
| 635,000 | |
| 835,000 | |
| 1,024,000 | |
| 901,000 | |
| 560,000 | |
| 1,135,000 | |
| 388,000 | |
| 0 | |
| 764,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |